Table 2

Time spent in hyperglycemia, defined as above 140, 180, and 250 mg/dL (7.8, 10, and 13.9 mmol/L)

Time spent in hyperglycemia*Intervention group: PLGM ONControl group: PLGM OFF
N4749
Time spent above 140 mg/dL (7.8 mmol/L)
 Mean (SD)936.3 (142.1)860.7 (150.4)
 Median938.8855.1
 Q1, Q3801.5, 1,023.1765.0, 963.3
 Wilcoxon test P = 0.0165
Time spent above 180 mg/dL (10 mmol/L)
 Mean (SD)597.5 (152.6)534.0 (147.1)
 Median571.6552.8
 Q1, Q3481.7, 711.3425.9, 612.8
 Wilcoxon test P = 0.0606
Time spent above 250 mg/dL (13.9 mmol/L)
 Mean (SD)189.3 (96.0)163.6 (96.7)
 Median204.5154.9
 Q1, Q3105.6, 230.396.7, 198.4
 Wilcoxon test P = 0.1311
  • *Time spent in hyperglycemia during 14-day study therapy, expressed as min/day.